Andrejs Erglis Selected Research

Length of Stay

9/2019

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Andrejs Erglis Research Topics

Disease

32	Myocardial Infarction 10/2022 - 03/2003
30	Thrombosis (Thrombus) 01/2022 - 02/2002
21	Coronary Artery Disease (Coronary Atherosclerosis) 04/2021 - 02/2002
20	Cardiovascular Diseases (Cardiovascular Disease) 01/2022 - 02/2002
13	Pathologic Constriction (Stenosis) 05/2022 - 03/2003
13	Death (Near-Death Experience) 01/2022 - 10/2006
8	Acute Coronary Syndrome 10/2022 - 04/2016
6	Coronary Disease (Coronary Heart Disease) 10/2022 - 01/2003
6	Stroke (Strokes) 09/2022 - 04/2013
6	Hypertension (High Blood Pressure) 05/2022 - 10/2010
6	ST Elevation Myocardial Infarction 03/2022 - 01/2011
5	Diabetes Mellitus 01/2021 - 08/2008
4	Ischemia 01/2022 - 11/2011
4	Heart Failure 01/2017 - 01/2015
3	Stable Angina 01/2018 - 08/2017
3	Coronary Stenosis (Coronary Artery Stenosis) 01/2018 - 08/2007
3	AIDS-Related Complex (ARC) 03/2015 - 08/2008
2	Atherosclerotic Plaque (Atheroma) 01/2022 - 01/2020
2	Knee Osteoarthritis 01/2019 - 01/2017
2	Inflammation (Inflammations) 03/2017 - 01/2017
2	Neointima 01/2016 - 06/2015
2	Type 2 Diabetes Mellitus (MODY) 10/2015 - 01/2003
2	Infarction (Infarctions) 03/2014 - 01/2013
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 05/2013 - 02/2011
1	Ischemic Stroke 10/2022
1	Unstable Angina 10/2022
1	COVID-19 03/2022
1	Human Influenza (Influenza) 11/2021
1	Vascular Remodeling 04/2021
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 04/2021
1	Systolic Heart Failure 01/2021
1	Shock 01/2021
1	Isolated Systolic Hypertension 01/2021
1	Cardiogenic Shock 01/2021
1	Atherosclerosis 01/2020
1	Endocarditis 09/2019
1	Hypotension (Low Blood Pressure) 01/2019
1	Coronary Occlusion 01/2018
1	Hyperplasia 12/2017
1	Osteoarthritis 01/2017
1	Pain (Aches) 01/2017
1	Overweight 04/2016
1	Chronic Renal Insufficiency 01/2016
1	Muscular Diseases (Myopathy) 01/2016
1	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 09/2015

Drug/Important Bio-Agent (IBA)

15	omega-Chloroacetophenone (Mace)IBA 10/2022 - 06/2011
7	MetalsIBA 12/2017 - 08/2007
5	Sirolimus (Rapamycin)FDA Link 01/2016 - 09/2006
4	oxidized low density lipoproteinIBA 05/2022 - 01/2014
4	Fluspirilene (Imap)IBA 01/2020 - 03/2013
4	Paclitaxel (Taxol)FDA LinkGeneric 09/2014 - 08/2007
3	Biomarkers (Surrogate Marker)IBA 04/2021 - 03/2014
3	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2019 - 01/2014
3	Phenobarbital (Luminal)FDA Link 01/2016 - 06/2004
2	alirocumabIBA 10/2022 - 01/2019
2	2'- deoxythymidylyl- (3'- 5')- 2'- deoxyadenosine (d(AT))IBA 05/2022 - 03/2015
2	LipidsIBA 01/2022 - 01/2014
2	MicroRNAs (MicroRNA)IBA 04/2021 - 01/2020
2	Insulin (Novolin)FDA Link 01/2021 - 01/2017
2	PolymersIBA 01/2020 - 03/2017
2	Glucose (Dextrose)FDA LinkGeneric 01/2019 - 10/2015
2	Pharmaceutical PreparationsIBA 12/2017 - 09/2013
2	LDL CholesterolIBA 09/2015 - 01/2014
2	Neprilysin (Neutral Endopeptidase)IBA 02/2015 - 01/2015
2	Angiotensin Receptors (Angiotensin II Receptor)IBA 02/2015 - 01/2015
2	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 02/2015 - 01/2015
2	sacubitril and valsartan sodium hydrate drug combinationIBA 02/2015 - 01/2015
1	CholesterolIBA 05/2022
1	Influenza Vaccines (Influenza Vaccine)FDA Link 11/2021
1	Circulating MicroRNAIBA 04/2021
1	Antihypertensive Agents (Antihypertensives)IBA 01/2021
1	Oxygen (Dioxygen)IBA 01/2019
1	lipoprotein cholesterolIBA 01/2019
1	Everolimus FDA Link 01/2018
1	Clopidogrel (Plavix)FDA Link 01/2018
1	ElementsIBA 03/2017
1	Hyaluronic Acid (Hyaluronan)IBA 01/2017
1	poly(bis(trifluoroethoxy)phosphazene)IBA 01/2017
1	EnzymesIBA 01/2016
1	PolyprenolsIBA 01/2016
1	DolicholsIBA 01/2016
1	coenzyme Q10 (CoQ10)IBA 01/2016
1	GliadinIBA 04/2015

Therapy/Procedure

39	Stents 03/2022 - 02/2002
24	Percutaneous Coronary Intervention 05/2022 - 09/2006
14	Therapeutics 05/2022 - 08/2008
13	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 01/2021 - 07/2012
13	Drug-Eluting Stents 01/2019 - 01/2011
2	Carotid Endarterectomy 01/2022 - 01/2021
2	Myocardial Revascularization 01/2018 - 01/2013
2	Secondary Prevention 04/2016 - 01/2015
2	Stem Cell Transplantation 05/2013 - 02/2011
1	Transcatheter Aortic Valve Replacement 09/2022
1	Patient Admission (Patient Admissions) 03/2022
1	Endarterectomy (Thromboendarterectomy) 01/2022
1	Extracorporeal Membrane Oxygenation 01/2021
1	Vascular Surgical Procedures 01/2020
1	Length of Stay 09/2019
1	Intra-Articular Injections 01/2019
1	Injections 01/2017